Shares of Scancell Holdings plc (LON:SCLP – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 16.65 and traded as high as GBX 23.50. Scancell shares last traded at GBX 22.50, with a volume of 418,329 shares trading hands.
Scancell Trading Down 0.4%
The company has a debt-to-equity ratio of -193.29, a quick ratio of 13.01 and a current ratio of 0.56. The company has a market cap of £232.46 million, a P/E ratio of -40.73 and a beta of 0.57. The stock has a 50-day moving average of GBX 16.65 and a two-hundred day moving average of GBX 13.36.
About Scancell
Scancell (LSE:SCLP) is a clinical stage company leveraging two proprietary platforms, Immunobody® and Moditope®, to develop targeted off-the-shelf, patient-accessible active immunotherapies for a cancer-free future. The lead product iSCIB1+ is an Immunobody® DNA active immunotherapy that has demonstrated monotherapy activity in adjuvant melanoma. When combined with checkpoint therapies it showed additional clinical benefit over the checkpoints (CPI) alone in the ongoing Phase 2 SCOPE trial in advanced melanoma.
Featured Stories
- Five stocks we like better than Scancell
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.
